Product Description
| Brand | Beckman Coulter |
| Sample Type | Serum/ Plasma |
| Pack Size | 2 x 50T |
| CAT No. | 34210 |
Application | Infectious disease |
Beckman Coulter Access HAV IgM (CLIA) Reagent Kit is a high-performance Hepatitis A Virus (HAV) IgM chemiluminescent immunoassay reagent kit designed for the automated qualitative detection of IgM antibodies to HAV in human serum or plasma. Utilizing advanced Chemiluminescent Immunoassay (CLIA) technology, the kit provides rapid, highly sensitive, and reliable results with excellent analytical performance.
Reliable Detection of HAV IgM AntibodiesThis reagent kit offers dependable, qualitative identification of IgM antibodies related to Hepatitis A virus. Its chemiluminescence technology ensures high sensitivity and specificity, supporting accurate laboratory diagnostics. The automatic operating system reduces manual intervention, providing consistent and reproducible outcomes every time.
User-Friendly and Portable SolutionDesigned for convenience, this HAV IgM CLIA kit is portable and suitable for standard laboratory settings. Its storage requirements (2 to 8C) are easy to accommodate, making it an adaptable choice for various laboratory environments and workflows.
Efficient and Real-Time ProcessingWith real-time operation capabilities, the kit enables swift processing of samples and rapid turnaround of results. This efficiency supports healthcare professionals in making timely decisions for patient diagnosis and management of Hepatitis A infection.
FAQ's of Beckman Coulter Access HAV IgM (CLIA):
Q: How does the Beckman Coulter Access HAV IgM (CLIA) reagent kit work?
A: This kit utilizes chemiluminescence immunoassay (CLIA) technology to qualitatively detect IgM antibodies against Hepatitis A Virus (HAV) in human samples. The process is fully automatic, yielding rapid and accurate results.
Q: What is the recommended storage condition for the HAV IgM CLIA reagent kit?
A: The reagent kit should be stored at a temperature between 2 to 8 degrees Celsius to maintain stability and ensure optimal performance.
Q: When should the Beckman Coulter Access HAV IgM (CLIA) kit be used?
A: This kit is used when laboratory professionals need to screen or confirm the presence of IgM antibodies to HAV, particularly for diagnosing current or recent Hepatitis A infection.
Q: Where can the reagent kit be utilized?
A: It is designed for laboratory use and can be deployed in medical centers, diagnostic labs, and hospital settings throughout India.
Q: What is the process for conducting a test with this reagent kit?
A: Samples are loaded onto an appropriate analyzer equipped to run CLIA, and the instrument automatically processes the samples, interprets the chemiluminescent signal, and provides a qualitative result.
Q: What benefits does the HAV IgM CLIA kit provide?
A: The kit offers reliable, real-time results that assist healthcare professionals in rapidly diagnosing Hepatitis A, improving patient management and care outcomes.
Q: Is the HAV IgM CLIA reagent kit easy to transport?
A: Yes, this reagent kit is designed to be portable, making it suitable for various laboratory settings and facilitating convenient distribution and use.